Âé¶¹´«Ã½

Enterprise Innovation

Âé¶¹´«Ã½Â Enterprise Innovation engages and collaborates with Âé¶¹´«Ã½ faculty and trainees while fostering alliances with leaders in the biomedical industry and business and investment community. Our focus is to translate the application of emerging science and new technologies into world-class medical breakthroughs.

Integrating Âé¶¹´«Ã½â€™s different teams and resources under a single, united organization, Enterprise Innovation encompasses the entire spectrum of an effective innovation ecosystem. We offer unique opportunities for faculty and trainees to transform their research into medical advances through collaborations including access to the Sanders Tri-Institutional Therapeutics Discovery Institute.

News

July 10, 2026

Âé¶¹´«Ã½ has received a four-year, $1.5 million grant from New York’s Empire State Development to increase resources available through BioVenture eLab, the...

June 17, 2026

A new gene therapy appears to be safe in patients diagnosed with Friedreich ataxia cardiomyopathy, a progressive and fatal inherited cardiac disease, according to a phase 1...

June 10, 2026

The eighth cohort of the Biomedical Innovation Challenge showcased its innovations and development plans during a lightning round of pitches and judges’ questions on June 4 in the...

Events

Jul 31, 2026
11:00am to 1:00pm
Aug 04, 2026
12:00pm to 1:30pm
Aug 07, 2026
11:00am to 1:00pm